In osteosarcoma, it was found that the microRNA-29 family may play a tumor inhibitory role in controlling methotrexate resistance and apoptosis by targeting COL3A1 or MCL1 apoptosis regulators. This evidence concerns the gene MCL1 and neoplasm.